224
34
160
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36832 |
PDE4B-IN-2
A 33 |
PDE | Metabolism |
PDE4B-IN-2 (A 33) 是一种具有口服活性,选择性 PDE4B 抑制剂,IC50 为 15 nM。PDE4B-IN-2 抑制 PDE4D (IC50=1.7 µM)。PDE4B-IN-2 表现出有效的抗炎作用。 | |||
TP1039 |
Secretin (33-59), rat
大鼠SECRETIN肽,Secretin (rat) |
Glucagon Receptor | GPCR/G Protein |
Secretin (33-59), rat (Secretin (rat)) 是由 27 个氨基酸组成的多肽。Secretin (33-59), rat 可作用于分泌素受体,能够增强胰腺的碳酸盐、酶和钾离子的分泌。 | |||
T6433 |
CAY10505
|
Apoptosis; PI3K | Apoptosis; PI3K/Akt/mTOR signaling |
CAY10505 是 AS-252424 的一种脱羟基形式,是作用于神经元细胞的选择性 PI3Kγ抑制剂,IC50为 33 nM。 | |||
T60067 |
WAY-297174
|
Casein Kinase | Metabolism; Stem Cells |
WAY-297174是一种人CK2的抑制剂,IC50 > 33μM。 | |||
T12216 |
NF-56-EJ40
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
NF-56-EJ40 是一种有效且高度特异性的人 SUCNR1 拮抗剂,IC50 为 25 nM,Ki 为 33 nM。 | |||
T76910 |
Astegolimab
RG 6149,MSTT 1041A |
Interleukin | Immunology/Inflammation |
Astegolimab (RG 6149) 是一种人源化靶向 IL-33 受体的 IgG2 单克隆抗体,可抑制 IL-33 信号传导。Astegolimab 可用于研究慢性阻塞性肺疾病 (COPD) 和成人严重哮喘。 | |||
T62929 |
RLX-33
|
ERK; RXFP receptor | GPCR/G Protein; MAPK |
RLX-33 是一种有效的、选择性的、能够透过血脑屏障的松弛素家族肽 3 (RXFP3) 拮抗剂,也能够阻断松弛素 3 (relaxin 3) 诱导的 ERK1/2 磷酸化。RLX-33 作用于 RXFP3、ERK1 和 ERK2 磷酸化的 IC50 分别为 2.36 μM、7.82 μM 和 13.86 μM。RLX-33 可以阻断 RXFP3 选择性激动剂 R3/I5 诱导的大鼠食物摄取增加。RLX-33 能够用于研究代谢综合征。 | |||
T5884 |
Chelidamic acid
4-氧代-1,4-二氢-2,6-吡啶二甲酸,白屈氨酸 |
GluR | Neuroscience |
Chelidamic acid 是一种有效的谷氨酸脱羧酶抑制剂(Ki:33 μM),也是含有吡喃骨架的杂环有机酸,与金属离子有良好的配位能力。 | |||
T6725 |
VU 0357121
|
GluR | Neuroscience |
VU 0357121 是一种高选择性的mGlu5R 正变构调节剂 ,EC50为 33 nM。 | |||
TP1973L |
OXA (17-33) acetate
|
OX Receptor | GPCR/G Protein; Neuroscience |
OXA (17-33) acetate 是一种比 OX2 (EC50 = 187 nM) 更有效的 orexin-1 受体 (OX1, EC50 = 8.29 nM)) 激动剂。 | |||
T13119 |
Tenalisib
RP6530 |
PI3K | PI3K/Akt/mTOR signaling |
Tenalisib (RP6530) 是一种新颖的,高效的,选择性的 PI3Kδ (IC50:25 nM) 和 PI3Kγ (IC50:33 nM) 抑制剂。 | |||
T12110 |
MRZ 2-514
8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one |
NMDAR | Neuroscience |
MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) 是 NMDA receptor(glycineB) 的拮抗剂,Ki=33 μM。 | |||
T6110 |
YM-201636
|
Influenza Virus; PI3K; Autophagy | Autophagy; Microbiology/Virology; PI3K/Akt/mTOR signaling |
YM201636 是是一种特异性 PIKfyve 抑制剂,IC50值为 33 nM,对 p110α的IC50为 3.3 μM。它还可抑制逆转录病毒复制。 | |||
T14364 |
AZ-Dyrk1B-33
3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) 是高选择性的Dyrk1B 激酶抑制剂,其IC50=7 nM。 | |||
TP2500 |
Cholecystokinin (26-33) free acid
CCK (26-33) free acid |
cholecystokinin | GPCR/G Protein |
Cholecystokinin (26-33) free acid 是胆囊收缩素 (CCK) 的一部分, 是脊椎动物中枢神经系统中存在的 CCKB 型受体的高选择性配体,可诱导大鼠轻度味觉厌恶条件反射。 | |||
T19618 |
(R)-(-)-JQ1 Enantiomer
(R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂环庚烷-6-基)乙酸叔丁酯 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
(R)-(-)-JQ1 Enantiomer 是 (+)-JQ1 的立体异构体。 (+)-JQ1 是一种 BET 溴结构域抑制剂,对BRD4(1/2)的IC50 为 77 和 33 nM。 | |||
T6840 |
FRAX486
|
PAK | Cytoskeletal Signaling |
FRAX486 是一种有效的 p21 活化激酶 (PAK) 抑制剂,对 PAK1、PAK2、PAK3 和 PAK4 的 IC50 值分别为 14、33、39 和 575 nM。 | |||
T8674 |
SR33805
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
SR33805 是钙通道拮抗剂,在去极化和极化条件下的 EC50值分别为 4.1 和 33 nM。它阻止 L 型 Ca2+通道,可用于研究急性或慢性心脏衰竭。 | |||
T5443 |
JQ-1 (carboxylic acid)
JQ-1 carboxylic acid |
Epigenetic Reader Domain | Chromatin/Epigenetic |
JQ-1 (carboxylic acid) 是一种细胞渗透性 BRD4 抑制剂,对 BRD4(1) 和 BRD4(2) 的 IC50 分别为 77 和 33 nM。它是一种 (+)-JQ1 衍生物,可作为合成 PROTACs 的前体。 | |||
T6840L |
FRAX486 HCL(1232030-35-1 free base)
|
PAK | Cytoskeletal Signaling |
FRAX486 HCL(1232030-35-1 free base) 是一种有效的 p21 活化激酶 (PAK) 抑制剂,对 PAK1、PAK2、PAK3 和 PAK4 的 IC50 值分别为 14、33、39 和 575 nM。 | |||
T7163 |
PF-05175157
|
Acetyl-CoA Carboxylase | Metabolism |
PF 05175157 是一种广谱的乙酰辅酶 A 羧化酶 (ACC) 抑制剂,对 ACC1 (human),ACC2 (human), ACC1 (rat) 和 ACC2 (rat) 具有抑制作用,IC50分别为 27.0, 33.0, 23.5 和 50.4 nM。 | |||
T12918 |
SIRT-IN-1
|
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
SIRT-IN-1 是一种有效SIRT1/2/3抑制剂,IC50分别为 15,10,33 μM。 | |||
T2505 |
S3I-201
S3I 201,S3I201 |
STAT | JAK/STAT signaling; Stem Cells |
S3I-201 (S3I-201) 是一种选择性Stat3抑制剂,IC50为 86 μM。 | |||
T2395L |
Vortioxetine hydrobromide
氢溴酸沃替西汀,Vortioxetine (Lu AA21004) HBr,Vortioxetine HBr,盐酸沃替西汀,Lu AA21004 hydrobromide |
5-HT Receptor; Serotonin Transporter | GPCR/G Protein; Neuroscience |
Vortioxetine hydrobromide (Lu AA21004 hydrobromide) 是5-HT1A、5-HT1B、5-HT3A、5-HT7受体和5-羟色胺转运体(SERT)的抑制剂,Ki 值分别为 15、33、3.7、19 和 1.6 nM。 | |||
T22260 |
Aminopurvalanol A
|
CDK | Cell Cycle/Checkpoint |
Aminopurvalanol A 是一种竞争性、选择性和细胞渗透性的Cyclins/Cdk 复合物抑制剂,优先靶向G2/M 期转变进而抑制癌细胞分化。它通过抑制生理获能依赖性肌动蛋白聚合而抑制精子受精能力。 | |||
T6208 |
AS-252424
|
Casein Kinase; PI3K | Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
AS252424 是一种有效的、选择性的 PI3Kγ 抑制剂,其 IC50=30±10 nM。 | |||
T6970 |
RK33
RK-33,RK 33 |
COX | Immunology/Inflammation; Neuroscience |
RK33 (RK 33) 是 DDX3(一种 RNA 解旋酶)的一流小分子抑制剂,可导致 G1 细胞周期停滞,诱导细胞凋亡,并促进 DDX3 过表达细胞的辐射增敏。 | |||
T2088 |
APD668
APD 668 |
GPR; P450; Potassium Channel | Endocrinology/Hormones; GPCR/G Protein; Membrane transporter/Ion channel; Metabolism |
APD668 是选择性的,口服有效的GPR119激动剂,对hGPR119和rGPR119的EC50分别为 2.7 nM 和 33 nM。它对除CYP2C9(Ki=0.1 μM) 以外的五种主要 CYP 亚型均无明显抑制作用。它可用于脂肪性肝炎和糖尿病的研究。 | |||
T77045 |
Itepekimab
REGN-3500,SAR-440340 |
Others | Others |
Itepekimab (REGN-3500) 是一种有效的抗 IL-33 的单克隆抗体。Itepekimab 在体内实验中可减少气道炎症和相关组织损伤,可用来研究哮喘疾病。 | |||
T2110 |
(+)-JQ-1
JQ1 |
Epigenetic Reader Domain; Autophagy; Ligands for Target Protein for PROTAC | Autophagy; Chromatin/Epigenetic; PROTAC |
(+)-JQ-1 (JQ1) 是一种 BET 溴结构域抑制剂,抑制 BRD4(1/2) (IC50=77/33 nM),具有特异性和可逆性。(+)-JQ-1 可以诱导细胞自噬,抑制细胞增殖。 | |||
T9548 |
RSM-932A
TCD-717 |
||
RSM-932A (TCD-717) 是一种特异性 ChoKα 抑制剂,对人重组 ChoKα 和 ChoKβ 酶的 IC50 分别为 1 和 33 μM。RSM-932A 具有有效的体内外抗肿瘤活性,并且毒性较低。 | |||
TP2047L |
CRF (6-33) acetate(120066-38-8 free base)
|
CRFR | GPCR/G Protein |
CRF (6-33) acetate(120066-38-8 free base) 是促肾上腺皮质激素释放因子结合蛋白 (CRFBP) 抑制肽;从 CRFBP 中替换 CRF。在体内抑制肥胖大鼠的体重增加并增加运动活动。 | |||
T5198 |
Bobcat339
盐酸Bobcat339,Bobcat339 hydrochloride |
DNA Methyltransferase | Chromatin/Epigenetic |
Bobcat339 是一种基于胞嘧啶的选择性TET 酶抑制剂,抑制TET1和TET2的IC50值分别为 33 和 73 μM。它可作为靶向 DNA 甲基化和基因转录新疗法的起点,用于表观遗传学领域研究。 | |||
T62228 |
KRAS G12D inhibitor 14
|
Ras | GPCR/G Protein; MAPK |
KRAS G12D inhibitor 14 是一种 KRAS G12D 的有效抑制剂,能够结合 KRAS G12D 蛋白 (Kd: 33 nM)。KRAS G12D inhibitor 14 抑制 KRAS G12D (KRAS G12D-GTP) 的活性形式,但对 KRAS G13D 无抑制作用。 | |||
T1994 |
Pictilisib
RG7321,GDC-0941 |
Apoptosis; PI3K; Autophagy | Apoptosis; Autophagy; PI3K/Akt/mTOR signaling |
Pictilisib (GDC-0941) 是一种PI3Kα/δ抑制剂,IC50为 3 nM。它对110β和 p110γ 具有适度的选择性,分别为11倍和25倍。 | |||
T6762 |
AS1842856
|
Autophagy; FOXO1 | Apoptosis; Autophagy |
AS1842856 是一种特异性的Foxo1抑制剂,IC50为 30 nM。它抑制自噬,直接与 FoxO1 结合而降低 FoxO1 的活性。 | |||
TP1597L |
Secretoneurin, rat acetate
Secretoneurin, rat acetate(149146-12-3 Free base) |
Others | Others |
Secretoneurin, rat acetate 是一种 33 个氨基酸的多肽,由分泌粒蛋白 II (SgII) 的蛋白水解加工产生。它在体内和体外诱导大鼠纹状体中的多巴胺释放,它对单核细胞和嗜酸性粒细胞有很强的趋化作用,但对粒细胞没有。 | |||
T14884 |
CBR-5884
|
Others; Dehydrogenase | Metabolism; Others |
CBR-5884 是一种磷酸甘油酸脱氢酶抑制剂,IC50为 33 μM。 它抑制癌细胞中的丝氨酸合成,选择性地抑制黑素瘤和乳腺癌细胞系的增殖,对具有高丝氨酸生物合成活性的癌细胞系有选择性毒性。 | |||
T3508 |
SEA0400
SEA 0400,2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺,SEA-0400 |
Calcium Channel; Na+/Ca2+ Exchanger | Membrane transporter/Ion channel; Metabolism |
SEA0400 是 Na+/Ca2+ 交换剂的选择性抑制剂,在培养的神经元、星形胶质细胞和小胶质细胞中,能够抑制 Na+-依赖性 Ca2+的吸收,IC50值为 5-33 nM。 | |||
T26873 |
BMY-27709
BMY 27709,BMY27709 |
Influenza Virus | Microbiology/Virology |
BMY-27709 是一种流感病毒生长抑制剂,对 A/WSN/33 病毒生长的 IC50 值为 3-8 μM,对流感病毒的部分亚型也展现出抑制活性。BMY-27709 对 H1 和 H2 病毒感染的早期起作用,通过抑制血凝素蛋白展现其抗病毒活性。然而,BMY-27709 对 H3 亚型病毒以及 B 型/Lee/40 流感病毒没有作用。 | |||
T12216L |
NF-56-EJ40 hydrochloride
|
GHSR | GPCR/G Protein |
NF-56-EJ40 hydrochloride 是一种有效,高亲和力和高度选择性的人 SUCNR1 (GPR91) 拮抗剂,IC50 为 25 nM,Ki 为 33.5 nM,对大鼠 SUCNR1 几乎没有活性。 NF-56-EJ40 hydrochloride 对人源化大鼠 SUCNR1 具有高亲和力,Ki 值为 17.4 nM。 | |||
T12266 |
Ilginatinib
NS-018 |
Tyrosine Kinases; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Ilginatinib (NS-018) 是一种可口服的JAK2强效抑制剂,IC50值为 0.72 nM,对其选择性是对 JAK1、JAK3和 Tyk2 的 46、54 和 22 倍,IC50分别为 33、39 和 22 nM。 | |||
T9149 |
2BAct
2B-Act,2B Act |
PERK | Apoptosis |
2BAct 是一种具有口服活性的高选择性真核起始因子eIF2B 活化剂,EC50为 33 nM。它可防止由慢性综合应激反应引起的神经系统缺陷。 | |||
TP1215L |
Abaloparatide acetate(247062-33-5 free base)
|
Others | Others |
Abaloparatide acetate(247062-33-5 free base) 是一种甲状旁腺激素受体 1 PTHR1 类似物,是 PTHR1 信号通路的有效和选择性激活剂。 | |||
T12266L |
Ilginatinib maleate
NS-018 maleate |
Tyrosine Kinases; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Ilginatinib maleate (NS-018 maleate) 是一种可口服的 JAK2强效抑制剂,IC50值为 0.72 nM,对其选择性是对 JAK1、JAK3和 Tyk2 的 46、54 和 22 倍,IC50分别为 33、39 和 22 nM。 | |||
T7502 |
PF 05089771 tosylate
|
Sodium Channel | Membrane transporter/Ion channel |
PF 05089771 tosylate 是口服有效的、选择性的Nav1.7丙烯酰胺抑制剂。PF 05089771 tosylate 具有用于疼痛和糖尿病神经性疾病的研究。 | |||
T12266L2 |
Ilginatinib hydrochloride
NS-018 hydrochloride |
Tyrosine Kinases; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Ilginatinib hydrochloride (NS-018 hydrochloride) 是一种可口服的 JAK2强效抑制剂,IC50值为 0.72 nM,对其选择性是对 JAK1、JAK3和 Tyk2 的 46、54 和 22 倍,IC50分别为 33、39 和 22 nM。 | |||
T2395 |
Vortioxetine
沃替西汀,Lu AA 21004 |
5-HT Receptor; Serotonin Transporter | GPCR/G Protein; Neuroscience |
Vortioxetine (Lu AA 21004) 是5-HT1A、5-HT1B、5-HT3A、5-HT7受体和 5-羟色胺转运体抑制剂,Ki 值分别为 15、33、3.7、19 和 1.6 nM。它作为抗抑郁药,用于治疗重度抑郁症。 | |||
TP2319 |
Thymosin β4 acetate(75591-33-4 free base)
|
Autophagy | Autophagy |
Thymosin β4 acetate(75591-33-4 free base) 是一种胸腺激素,具有多种不同的细胞内和细胞外活性,影响伤口愈合、炎症、纤维化和组织再生。 | |||
T6410 |
Bexarotene
Ro 26-4455,Targretin,蓓萨罗丁,贝沙罗汀,LGD1069 |
Retinoid Receptor; Autophagy | Autophagy; Metabolism |
Bexarotene (LGD1069) 是一种高亲和力的选择性类视黄醇 X 受体 (RXR) 激动剂,对 RXRα、RXRβ和 RXRγ的 EC50分别为 33、24和25 nM。它是一种类视黄醇类似物,用于治疗皮肤 T 细胞淋巴瘤的皮肤表现。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19124 |
3-Oxocholic acid
3-Ketocholic acid |
Endogenous Metabolite | Metabolism |
3-Oxocholic acid(3-Ketocholic acid) 是胆汁酸的代谢产物,也是产气荚膜梭菌在肠道中由胆汁降解的主要产物。33-Oxocholic acid 是一种主要存在于哺乳动物的胆汁中类固醇酸。 | |||
T1626 |
Prostaglandin E1
前列地尔,PGE1,列腺素E1,Alprostadil |
Endogenous Metabolite; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism |
Prostaglandin E1 (Alprostadil) 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 | |||
TN6076 |
Delbonine
14-O-Acetyldeltatsine,14-O-乙酰基德尔塔生 |
||
Delbonine 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6076,CAS号为 95066-33-4。 | |||
TN6781 |
SarMentine
|
||
SarMentine 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6781,CAS号为 78910-33-5。 | |||
TN6022 | Stephavanine | ||
Stephavanine 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6022,CAS号为 33116-33-5。 | |||
TMS1460 |
Qingyangshengenin A
|
Others | Others |
Qingyangshengenin A 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TMS1460,CAS号为 106644-33-1。 | |||
TN6189 | Koenigine | ||
Koenigine 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6189,CAS号为 28513-33-9。 | |||
TMA0343 |
Mellein
|
Others | Others |
Mellein是一种天然产物,属于番荔枝科哥纳香属,其产品编号为 TMA0343,CAS号为 480-33-1。Mellein可用作对照参考。 | |||
TN5868 |
8-Hydroxythymol
p-Cymene-3,8-diol,8-羟基百里香酚 |
||
8-Hydroxythymol 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5868,CAS号为 4478-33-5。 | |||
TN6236 |
Taraxinic acid
|
||
Taraxinic acid 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6236,CAS号为 75911-33-0。 | |||
TN3640 |
Chlorantholide A
|
Others | Others |
Chlorantholide A 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN3640,CAS号为 1372558-33-2。 | |||
TN3398 |
Alstolenine
|
Others | Others |
Alstolenine是一种天然产物,属于夹竹桃科鸡骨常山属,其产品编号为 TN3398,CAS号为 85769-33-1。Alstolenine可用作对照参考。 | |||
TN6354 |
Trigochinin C
|
||
Trigochinin C 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6354,CAS号为 1210299-33-4。 | |||
TN4095 |
gamma-Diasarone
|
Others | Others |
gamma-Diasarone 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4095,CAS号为 80434-33-9。 | |||
TN6643 |
Bruceantinol B
|
||
Bruceantinol B 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6643,CAS号为 1822332-33-1。 | |||
TN4553 |
Methyl pseudolarate A
|
Others | Others |
Methyl pseudolarate A是一种天然产物,属于松科金钱松属,其产品编号为 TN4553,CAS号为 82508-33-6。Methyl pseudolarate A可用作对照参考。 | |||
TN4378 | Kanshone H | Others | Others |
Kanshone H 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4378,CAS号为 1445952-33-9。 | |||
TN5689 |
2-(2,4-Dihydroxybenzoyl)benzoic acid
Monosodium salt form |
||
2-(2,4-Dihydroxybenzoyl)benzoic acid 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5689,CAS号为 2513-33-9。 | |||
T75570 |
Justicidin C
|
||
Justicidin C 是一种抗病毒木脂素,对水泡性口炎病毒展现了较强的抗病毒活性,同时在兔肺细胞(RL-33)中显示较低的细胞毒性。 | |||
TN1306 |
6-Feruloylcatalpol
|
Others | Others |
6-Feruloylcatalpol是一种天然产物,属于车前科胡黄连属,其产品编号为 TN1306,CAS号为 770721-33-0。6-Feruloylcatalpol可用作对照参考。 | |||
TN2782 |
2''-O-Acetylsprengerinin C
|
Others | Others |
2''-O-Acetylsprengerinin C 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN2782,CAS号为 1220707-33-4。 | |||
T31135 |
Cycloechinulin
|
||
Cycloechinulin is a diketopiperazine fungal metabolite originally isolated from A. ochraceus. It reduces weight gain of corn earworms by 33% compared to controls when used at a dose of 100 ppm in the diet. | |||
TN2981 | 3-Phenyl-1,2-dihydroacenaphthylene-1,2-diol | Others | Others |
3-Phenyl-1,2-dihydroacenaphthylene-1,2-diol 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN2981,CAS号为 193892-33-0。 | |||
TN4688 | O-Methylpallidine | Others | Others |
O-Methylpallidine是一种天然产物,属于番荔枝科索木属,其产品编号为 TN4688,CAS号为 27510-33-4。O-Methylpallidine可用作对照参考。 | |||
TN6610 |
Cyanidin-3-O-sambubioside-5-O-glucoside chloride
|
||
Cyanidin-3-O-sambubioside-5-O-glucoside chloride 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN6610,CAS号为 53925-33-0。 | |||
TN5586 |
14-Deoxy-12-hydroxyandrographolide
|
||
14-Deoxy-12-hydroxyandrographolide是一种天然产物,属于爵床科穿心莲属,其产品编号为 TN5586,CAS号为 219721-33-2。14-Deoxy-12-hydroxyandrographolide可用作对照参考。 | |||
T35910 |
Petromurin C
|
||
Petromurin C is a bis-indolyl benzenoid fungal metabolite originally isolated from the ascostromata of P. muricatus. It is cytotoxic to NS-1 mouse myeloma cells (IC50 = 33 μg/ml) and has activity against T. foetus in vitro (IC50 = 100 μg/ml). | |||
TN2479 |
1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine
|
Others | Others |
1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine是一种天然产物,属于莲叶桐科莲叶桐属,其产品编号为 TN2479,CAS号为 872729-33-4。1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine可用作对照参考。 | |||
TN5399 | 4α,8β-Dihydroxy-3α-(2-hydroxy-3-acetoxy-2-methylbutyryloxy)eudesm-7(11)-en-12,8α-olide | ||
4α,8β-Dihydroxy-3α-(2-hydroxy-3-acetoxy-2-methylbutyryloxy)eudesm-7(11)-en-12,8α-olide 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5399,CAS号为 1442989-33-4。 | |||
TN2874 |
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran
|
Others | Others |
3,4-Dihydro-2,2-dimethyl-2H-naphtho_1,2-b_pyran是一种天然产物,属于茜草科拉拉藤属,其产品编号为 TN2874,CAS号为 16274-33-2。3,4-Dihydro-2,2-dimethyl-2H-naphtho_1,2-b_pyran可用作对照参考。 | |||
T36992 |
Monocerin
|
||
Monocerin is a fungal metabolite that has been found inF. larvarumand has diverse biological activities.1,2,3It is active against the bacteriaE. coliandB. megaterium, the phytopathogenic fungusM. violaceum, and the algaC. fuscain an agar diffusion assay when used at a concentration of 50 μg/disc.1Monocerin (17.5 μg/ml) induces mortality in adultC. erythrocephala.2It reduces root elongation in pre-germinatedS. halepenseseeds when used at a concentration of 33 ppm.3 1.Zhang, W., Krohn, K., Draeger... | |||
T38243 |
Hygrolidin
|
||
Hygrolidin is a macrocyclic lactone originally isolated from S. hygroscopicus. It inhibits proliferation of a variety of cancer cell lines, including DLD-1 colon cancer, LNCaP prostate cancer, and K562 leukemia cells (IC50s = 2.9, 5.2, and 33 ng/ml, respectively). Hygrolidin induces the expression and levels of p21 in DLD-1 cells, but not WI-38 fibroblasts, and leads to cell accumulation in the G1 and S phases without inducing apoptosis. It has antiparasitic activity against T. cruzi, L. donovan... | |||
T80950 |
Tricetin 7-O-glucoside
|
||
Tricetin 7-O-glucoside (compound 33)为一种黄酮类单-O-糖苷。 | |||
T37451 |
Stachybotrysin B
|
||
Stachybotrysin B is a fungal metabolite originally isolated from S. chartarum and has antiviral and anticancer activities.1,2 It has antiviral activity against HIV in SupT1 cells (IC50 = 19.2 μM).1 Stachybotrysin B is cytotoxic to K562, HeLa, and HL-60 cells (IC50s = 21.72, 39.63, and 18.5 μM, respectively).2 |1. Zhao, J., Feng, J., Tan, Z., et al. Stachybotrysins A-G, phenylspirodrimane derivatives from the fungus Stachybotrys chartarum. J. Nat. Prod. 80(6), 1819-1826 (2017).|2. Ma, X.-h., Zhen... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02012 |
A33 Protein, Human, Recombinant (His)
glycoprotein A33 (transmembra... |
Human | HEK293 Cells |
A33 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25 kDa and the accession number is Q99795-1. | |||
TMPK-01148 |
GPA33/A33 Protein, Human, Recombinant (His & Avi), Biotinylated
A33,GPA33,MGC129986,MGC1... |
Human | HEK293 Cells |
GPA33/A33 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 26.5 kDa and the accession number is Q99795-1. | |||
TMPK-01147 |
GPA33/A33 Protein, Human, Recombinant (His & Avi)
A33,Glycoprotein A33,MGC... |
Human | HEK293 Cells |
GPA33/A33 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 26.5 kDa and the accession number is Q99795-1. | |||
TMPY-01788 |
JAM-A Protein, Mouse, Recombinant (hFc)
ESTM33,F11 receptor,JAM,JAM-A... |
Mouse | HEK293 Cells |
JAM-A Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50.2 kDa and the accession number is O88792. | |||
TMPY-05321 |
CYP3A4 Protein, Human, Recombinant (His)
P450C3,P450PCN1,CYPIIIA4,CP34,cytochrome P450 f... |
Human | E. coli |
CYP3A4 is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants. Human cytochrome P450 3A4 (CYP3A4) is an important drug metabolizing enzyme involved in a number of drug-drug and food-drug interactions. Systemic inflammation has been linked to suppressed CYP3A4 activity. | |||
TMPY-04837 |
Influenza A H3N2 (A/Johannesburg/33/1994) Hemagglutinin/HA Protein (His)
Harvey rat sarcoma vir |
H3N2 | Baculovirus Insect Cells |
Influenza A H3N2 (A/Johannesburg/33/1994) Hemagglutinin/HA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 59.4 kDa and the accession number is I6TFC9. | |||
TMPY-04744 |
Influenza A H3N2 (A/Johannesburg/33/1994) Hemagglutinin/HA1 Protein (His)
Harvey rat sarcoma vir |
H3N2 | HEK293 Cells |
Influenza A H3N2 (A/Johannesburg/33/1994) Hemagglutinin/HA1 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 38.1 kDa and the accession number is I6TFC9. | |||
TMPY-00165 |
Influenza A H7N8 (A/mallard/Netherlands/33/2006) Hemagglutinin/HA1 Protein (His)
Harvey rat sarcoma vir |
H7N8 | HEK293 Cells |
Influenza A H7N8 (A/mallard/Netherlands/33/2006) Hemagglutinin/HA1 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 36.5 kDa. | |||
TMPY-02410 |
Influenza A H7N8 (A/mallard/Netherlands/33/2006) Hemagglutinin/HA Protein (His)
Harvey rat sarcoma vir |
H7N8 | Baculovirus Insect Cells |
Influenza A H7N8 (A/mallard/Netherlands/33/2006) Hemagglutinin/HA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 59 kDa and the accession number is C5E6J1. | |||
TMPJ-01210 |
IL-33 Protein, Mouse, Recombinant
Interleukin-1 family member 11,白细胞介素,NF-HEV a |
Mouse | E. coli |
Mouse Interleukin 33 (IL-33) is a 30 kDa proinflammatory cytokine which may also regulates gene transcription in producer cells. IL-33 is constitutively expressed in smooth muscle and airway epithelia. IL-33 was identified based on sequence and structural homology with IL-1 family cytokines. It is up‑regulated in arterial smooth muscle, dermal fibroblasts, and keratinocytes following IL-1 alpha or IL‑1 beta stimulation. IL-33 is structurally related to IL-1, which induces helper T cells to produ... | |||
TMPK-00163 |
IL-33 Protein, Cynomolgus, Recombinant (His)
IL1F11,C9orf26 Z,C9ORF26,DV27,RP11-575C20.2,NFEHEV,IL33<... |
Cynomolgus | HEK293 Cells |
Interleukin-33 (IL-33) is a cytokine belonging to the IL-1 family, playing a role in inflammatory, infectious and autoimmune diseases and expressed in the cellular nucleus in several tissues. High levels of IL-33 are expressed in epithelial barrier tissues and endothelial barriers. ST2 is a receptor for IL-33, expressed selectively on a subset of Th2 cells, mediating some of their functions. | |||
TMPH-03115 |
IL-33 Protein, Pig, Recombinant (GST)
|
Sus scrofa (Pig) | E. coli |
N/A. IL-33 Protein, Pig, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 44.6 kDa and the accession number is M5B263. | |||
TMPJ-00617 |
IL-33 Protein, Rhesus macaque, Recombinant (His)
Interleukin-33,IL1F11,IL33,白介素,白细胞介素,IL-1F... |
Rhesus | E. coli |
Interleukin-33 (IL-33) belongs to the IL-1 superfamily. IL33 is highly expressed in endothelial venules found in tonsils, Peyer patches and mesenteric lymph nodes, but almost undetectable in placenta. IL33 induces the production of T helper-2 (Th2)-associated cytokines. IL-33 is a cytokine that mediates its biological effects by binding to and signals through IL1RL1/ST2 and IL-1 Receptor Accessory Protein (IL1RAP), activating intracellular molecules in the NF-κB and MAP kinase signaling pathways... | |||
TMPH-02287 |
ZRANB1 Protein, Human, Recombinant (His & Myc)
|
Human | E. coli |
Specifically hydrolyzes 'Lys-29'-linked and 'Lys-33'-linked diubiquitin. Also cleaves 'Lys-63'-linked chains, but with 40-fold less efficiency compared to 'Lys-29'-linked ones. Positive regulator of the Wnt signaling pathway that deubiquitinates APC protein, a negative regulator of Wnt-mediated transcription. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the stress fiber dynamics and cell migration. May also modulate TNF-alpha signaling. ZRANB1 Prot... | |||
TMPJ-01448 |
3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant (His)
M Proteinase,3CL Proteinase |
2019-nCoV | E. coli |
The viral main proteinase (M pro , also called 3CL pro ), which controls the activities of the coronavirus replication complex. It functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for coronavirus replication and is considered as an appealing target for designing anti-SARS agents. 3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant (His) is expressed in E. coli expression system with N-6xHis t... | |||
TMPK-01222 |
APLN Protein, Mouse, Recombinant (hFc)
APJ endogenous ligand,APEL,A<... |
Mouse | HEK293 Cells |
Macrophages play key roles during cardiovascular diseases (CVD) and their related complications.Apelin (APLN) is a key molecule, whose roles during CVD have been documented previously. Therefore, it has been hypothesized that APLN may perform its roles via modulation of macrophages. Additionally, due to the widespread distribution of the CVD, more effective therapeutic strategies need to be developed to overcome the related complications. APLN Protein, Mouse, Recombinant (hFc) is expressed in HE... | |||
TMPH-03059 |
Newcastle disease virus (NDV) (strain Her/33) Hemagglutinin-neuraminidase Protein (His)
|
NDV | E. coli |
Mediates the viral entry into the host cell together with fusion/F protein. Attaches the virus to sialic acid-containing cell receptors and thereby initiates infection. Binding of HN protein to the receptor induces a conformational change that allows the F protein to trigger virion/cell membranes fusion.; Neuraminidase activity ensures the efficient spread of the virus by dissociating the mature virions from the neuraminic acid containing glycoproteins. Newcastle disease virus (NDV) (strain Her/... | |||
TMPJ-00667 |
DEFB4A Protein, Human, Recombinant
DEFB4,DEFB4A,hBD-2,Beta-Defensin 2,Skin- |
Human | E. coli |
β-Defensin 4A is a membrane-active cationic peptide that functions in inflammation and innate immune responses. There are at least 30 β-Defensins, which are distinguished from α-Defensins by the connectivity pattern of their three intermolecular disulfide bonds. Members of the Defensin family are highly similar in protein sequence. This gene encodes Defensin, DEFB4;, which has broad-spectrum antimicrobial activity and may play an important role in innate epithelial defense. They are highly expre... | |||
TMPJ-01361 |
Siglec-8 Protein, Human, Recombinant (mFc)
CD329 antigen,Siglec-8,SAF2SAF-2,... |
Human | HEK293 Cells |
Siglec-8 is also known as SIGLEC8, SAF2, SIGLEC-8, SIGLEC8L and sialic acid binding Ig like lectin 8, is an approximately 75 kDa transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Siglec-8 is expressed on eosinophils, basophils, and mast cells, and it shows a binding preference for the carbohydrate 6-O sulfated sLex. At the tissue level, Siglec-8 mRNA was found to be most highly expressed in lung, PBMCs, spleen, and kidney. Mature human Siglec-8 c... | |||
TMPJ-00835 |
FGF-4 Protein, Mouse, Recombinant
HSTF1,HST-1,FGF4,FGF-4,HBGF-4,Fibroblast growth f |
Mouse | E. coli |
Fibroblast growth factor 4(FGF-4) is a heparin binding member of the FGF family. The human FGF4 cDNA encodes 206 amino acids (aa) with a 33 aa signal sequence and a 173 aa mature protein with an FGF homology domain that contains a heparin binding region near the C-terminus. Mature human FGF4 shares 91%, 82%, 94% and 91% aa identity with mouse, rat, canine and bovine FGF4, respectively. Human FGF-4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors, FGF R1c, 2... | |||
TMPK-01426 |
Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi)
HLA-A*02:01,Peptide Ready,MHC |
Human | HEK293 Cells |
Peptide Ready HLA-A*11:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*11:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01419 |
Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HLA-A*02:01,Peptide Ready |
Human | HEK293 Cells |
Peptide Ready HLA-A*03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01421 |
Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
HLA-A*02:01,MHC,Peptide Ready |
Human | HEK293 Cells |
HLA-A*02:01&B2M&Peptide ready Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01420 |
Peptide Ready HLA-A*03:01&B2M Monomer Protein, Human, MHC (His & Avi)
Peptide Ready,MHC,HLA-A*02:01 |
Human | HEK293 Cells |
Peptide Ready HLA-A*03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01422 |
Peptide Ready HLA-A*02:01&B2M Monomer Protein, Human, MHC (His & Avi)
Peptide Ready,MHC,HLA-A*02:01 |
Human | HEK293 Cells |
Peptide Ready HLA-A*02:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01425 |
Peptide Ready HLA-A*11:01&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HLA-A*02:01,Peptide Ready |
Human | HEK293 Cells |
Peptide Ready HLA-A*11:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*11:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01410 |
Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi)
HLA-A,MHC,Peptide Ready |
Human | HEK293 Cells |
Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01409 |
Peptide Ready HLA-A*24:02&B2M Monomer Protein, Human, MHC (His & Avi), Biotinylated
Peptide Ready,MHC,HLA-A |
Human | HEK293 Cells |
Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01415 |
APC-equivalent Peptide Ready HLA-A*02:01&B2M Tetramer Protein, Human, MHC (His)
Peptide Ready,HLA-A*02:01,MHC |
Human | HEK293 Cells |
Peptide Ready HLA-A*02:01&B2M Tetramer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner. | |||
TMPK-01427 |
HLA-A*11:01&B2M&KRAS G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
C-K-RAS,K-RAS4B,GTPase Kra |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01403 |
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
K-Ras 2,KI-RAS,CFC2,KRAS1,GTP... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01448 |
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein, Human, MHC (E. coli, His & Avi)
MHC,LAGE-2,NY-ESO-1,ESO1CTAG,MY-ESO-1,CT |
Human | E. coli |
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy. | |||
TMPK-01399 |
HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
K-RAS2A,NS3,KRAS2,CFC2,K-RA |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01404 |
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
NS,KRAS,KRAS1,KRAS2,MHC,RA |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01467 |
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His & Avi)
HPV16,E6,Human papillomavirus typ... |
Human | HEK293 Cells |
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer. | |||
TMPK-01479 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
NS3,KRAS1,K-Ras 2,K-RAS2A |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01520 |
HLA-A*02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein, Human, MHC (His & Avi)
Alpha-1-fetoprotein,AFP,HPA |
Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response. | |||
TMPK-01444 |
HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Tetramer Protein, Human, MHC (His & Avi)
MZ2-E,MAGE1A,MAGE-1 anti... |
Human | HEK293 Cells |
MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors. | |||
TMPK-01474 |
HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His & Avi)
|
Human | HEK293 Cells |
Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa. | |||
TMPK-01470 |
HLA-A*02:01&B2M&MAGE-A4 or MAGE-A8 (KVLEHVVRV) Monomer Protein, Human, MHC (His & Avi)
MAGE-A4 or MAGE-A8,M... |
Human | HEK293 Cells |
MAGE-A4 and MAGE-A8 are type I membes of the melanoma associated antigen (MAGE) family. The MAGE family is a large, highly conserved group of proteins that share a common MAGE homology domain. Both MAGE-A4 and MAGE-A8 antigen-presenting peptides can be presented by HLA-A*02:01. | |||
TMPK-01525 |
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
CFC2,RALD,K-Ras 2,MHC,C-K-RAS,NS3... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01461 |
HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi)
C-K-RAS,KRAS,RASK2,K-Ras... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01434 |
HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein, Human, MHC (His & Avi)
RASK2,CFC2,GTPase Kras,KRA |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01417 |
HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
Alpha-1-fetoprotein,HPAFP,A |
Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response. | |||
TMPK-01446 |
HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His & Avi)
MAGE1,MAGE1A,MAGE-1 ... |
Human | HEK293 Cells |
MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors. | |||
TMPK-01481 |
HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
svn 2B,svn-2B,Survivin-2B |
Human | HEK293 Cells |
Survivin-2B, a known splice variant of survivin, has been reported to promote cell death in some cancer cells, although it keeps prosurvival function in others.survivin-2B promoted autophagy and further regulated cell death by accumulating and stabilizing IKK alpha in the nucleus. | |||
TMPK-01494 |
HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Tetramer Protein, Human, MHC (His & Avi)
HLA-A,HLA-A*0101,HLA... |
Human | HEK293 Cells |
Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy. | |||
TMPK-01530 |
HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,LMP-2,PSMB9,LMP2,Macropain cha |
Human | HEK293 Cells |
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of ma... | |||
TMPK-01519 |
HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His & Avi)
MHC,FETA,AFP,Alpha-feto,... |
Human | HEK293 Cells |
Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A*02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed proteins.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response. | |||
TMPK-01513 |
HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
CT6.1,LAGE2A,MHC,CTAG1B,CTA |
Human | HEK293 Cells |
NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy. | |||
------------------------ 更多 ------------------------ |